Patient Registry Software Market Shows Unbelievable Growth worldwide by 2032 | FMI

Comments · 60 Views

“Increasing chronic diseases across the globe is anticipated to play an important role in driving the market. With the growing cases of cancer, cardiovascular, and diabetes, there has been a notable rise in demand for EHRs, which will impact the market positively in the coming time.”

The global Patient Registry Software Market is expected to reach US$ 4.4 billion by 2032, up from US$ 1.9 billion in 2022, at a CAGR of 8.8% from 2022 to 2032. Increased revenue can be attributed to the rising prevalence of chronic diseases and the growing geriatric population.

Get Full Access @ https://www.futuremarketinsights.com/reports/patient-registry-software-market

Increased use of electronic health records and increased use of stored data for post-marketing surveillance, as well as the implementation of favorable government initiatives, are expected to play a significant role in strengthening the market during the forecast period. Furthermore, with rising cost-cutting pressures and increased access to social media and mobile technologies, the healthcare sector is undergoing a significant transformation, which is expected to benefit the patient registry software market during the forecast period.

Key Takeaways from the Market Study

  • The global patient registry market is expected to garner US$ 1.9 Billion in 2022
  • Global market demand flourished at a 10.4% CAGR from 2015 to 2021
  • The commercial registry software segment to expand at 8.9% from 2022 to 2032
  • The US market size to garner US$ 1.5 Billion by 2032
  • Market in Brazil to value US$ 57 Million from 2022- to 2032
  • The CAGR of China is expected to be 10.5% from 2022 to 2032
  • The diabetes registry segment is projected to experience a CAGR of 9.3% from 2022 to 2032

“Increasing chronic diseases across the globe is anticipated to play an important role in driving the market. With the growing cases of cancer, cardiovascular, and diabetes, there has been a notable rise in demand for EHRs, which will impact the market positively in the coming time.”

Competition Analysis 

Key players in the global patient registry software market include Dacima Software Inc., Evado eClinical Solutions, IQVIA, Global Vision Technologies Inc., and Invitae. Recent developments among key players are:

  • In June 2020, ArborMetrix Inc. (US) entered into a strategic partnership with The Society of Interventional Radiology (SIR). The initiative aims to offer the IR Quality Registry to enhance patient care by deploying analytics.
  • In March 2021, ESO Solutions announced a strategic partnership with Virginia EMS Systems (US) to provide an EMS data repository and trauma registry across the state.
  • In April 2021, IQVIA Holdings accomplished the remaining 40% of Q2 solutions from diagnostic information services providers Quest Diagnostics.
  • In December 2020, ImageTrend, Inc. (US) disclosed the latest National Trauma Data Bank (NTDB) Data Dictionary that would be available in the Patient Registry from January 1, 2021.

Key Segments Covered in the Patient Registry Software Market Report

Patient Registry Software by Type:

  • Public Domain Patient Registry Software
  • Commercial Patient Registry Software

Patient Registry Software by Disease Area:

  • Diabetes Patient Registry Software
  • Cardiovascular Patient Registry Software
  • Cancer Patient Registry Software
  • Rare Disease/Orphan Disease Patient Registry Software
  • Other Chronic Disease Patient Registry Software

Full Information Source @ https://www.futuremarketinsights.com/reports/patient-registry-software-market

Patient Registry Software by End User:

  • Patient Registry Software for Governments
  • Patient Registry Software for Commercial Use
Comments